Kjellstrand C M
Department of Medicine, Karolinska Hospital, Stockholm, Sweden.
Acta Med Scand Suppl. 1988;725:1-88.
High-technology medicine, such as dialysis and transplantation is limited and nowhere can all potential beneficiaries receive it. Although very successful, high-technology medicine sometimes makes dying to a cruel spectacle and patients whose lives depend on a machine want to stop. The resulting ethical questions revolve around just distribution of life support - giving life, and withdrawal of life support in giving death. We investigated distributive justice of life-support by setting the number of patients accepted for dialysis in relation to those who died of renal failure and by setting the transplanted patients in relation to those waiting on chronic dialysis. In both Sweden and in the USA, and in both dialysis and transplantation, older patients received less treatment than younger ones. Seventy-year old people had less than 1/10 the chance of 20-40 year old of receiving dialysis and less than 1/30 chance of receiving a transplant. Women had between 70%-90% the chance of men of receiving dialysis and transplantation in both countries. Black people were more often dialyzed, but less often transplanted in the USA. Neither in Sweden, nor in the USA has distributive justice been achieved in dialysis and transplantation. Similar problems have been reported in other areas of high-technology medicine. We studied withdrawal, i.e. passive euthanasia, in chronic dialysis patients and found that 10% of all patients who begun dialysis died because it was stopped, although there was no medical or technical reason. Stopping caused 22% of all dialysis deaths. Half of those who died because dialysis was stopped, made the decision to stop treatment themselves. The other half was incompetent and families and physicians decided to discontinue treatment and let the patient die. The competent and incompetent patients were similar and the decisions seem to have been made on the same ground in both groups suggesting that families and physicians are appropriate surrogate decision-makers for incompetent patients. Home dialysis patients withdrew from dialysis, three times more often than center dialysis patients. The decision did not seem to harm the surviving relatives, but the relatives complained of poor physician communication. Old patients had shorter survival on dialysis, were more often excluded from, and stopped dialyses ten times more often than young patients. However, the ratio of mortality on dialysis compared to the mortality in the population at large was higher in young than in old patients and the self-reported quality of life of the old patients was particularly high.(ABSTRACT TRUNCATED AT 400 WORDS)
高科技医学,如透析和移植,是有限的,并非所有潜在受益者都能获得。尽管非常成功,但高科技医学有时会让死亡成为一种残酷的景象,那些依赖机器维持生命的患者想要停止治疗。由此产生的伦理问题围绕着生命支持的公正分配——给予生命,以及在给予死亡时撤回生命支持。我们通过设定接受透析的患者数量与死于肾衰竭的患者数量的关系,以及设定移植患者数量与等待长期透析的患者数量的关系,来研究生命支持的分配正义。在瑞典和美国,无论是透析还是移植,老年患者接受的治疗都比年轻患者少。70岁的人接受透析的机会不到20至40岁人群的1/10,接受移植的机会不到1/30。在这两个国家,女性接受透析和移植的机会是男性的70%至90%。在美国,黑人接受透析的频率更高,但接受移植的频率更低。在瑞典和美国,透析和移植都没有实现分配正义。在高科技医学的其他领域也报告了类似的问题。我们研究了慢性透析患者的撤机情况,即被动安乐死,发现所有开始透析的患者中有10%因透析停止而死亡,尽管没有医学或技术原因。透析停止导致了所有透析死亡病例的22%。因透析停止而死亡的患者中,有一半是自己决定停止治疗的。另一半无行为能力,由家人和医生决定停止治疗,让患者死亡。有行为能力和无行为能力的患者情况相似,两组的决定似乎都是基于相同的理由做出的,这表明家人和医生是无行为能力患者合适的替代决策者。家庭透析患者停止透析的频率是中心透析患者的三倍。这个决定似乎没有伤害到幸存的亲属,但亲属抱怨医生沟通不佳。老年患者透析后的生存期较短,被排除在透析之外的情况更频繁,停止透析的频率是年轻患者的十倍。然而,年轻患者透析死亡率与总体人群死亡率的比率高于老年患者,而且老年患者自我报告的生活质量特别高。(摘要截取自400字)